We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Wearable ECG Monitor Enables Highly Accurate, Sensitive and Specific Detection of Atrial Fibrillation

By HospiMedica International staff writers
Posted on 15 May 2023

Atrial fibrillation (AF), the most prevalent tachyarrhythmia, is linked to increased stroke risk. However, diagnosing AF is clinically challenging due to its asymptomatic and intermittent nature. Portable single-channel ECG devices provide a more efficient method for AF screening compared to 24-hour Holter monitoring. Now, a wearable ECG and movement sensor can help catch arrhythmias that are often missed in 24-hour Holter measurements.

Movesense Medical from Movesense Ltd. (Vantaa, Finland) is a compact wearable sensor designed to measure single-channel ECG, heart rate, heart rate variability, and human motion. Due to its discreet design and ease of use, Movesense Medical is particularly useful for remote patient monitoring and other telemedicine applications. Patients can use the device independently, reducing the burden on healthcare staff and facilitating monitoring as required. It can serve as a supplement to traditional, costlier Holter monitors, thereby freeing up healthcare professionals for other tasks. In ECG monitoring, it assists in detecting arrhythmias that 24-hour Holter measurements often miss.

Movesense Medical is designed for single-channel ambulatory ECG measurement and precise quantitative data on human movement. It allows for the examination of the human heart and the effects of body condition, disease, or injury on the movement system. Movesense Medical is programmable and can run custom algorithms to process data locally on the sensor. It transmits the measured signals to other devices for storage, visualization, and further data analysis. The validated 1-lead ECG, heart rate, and heart rate intervals offered by Movesense Medical are ready to be integrated with existing health applications. The outcome is an affordable, lightweight, wearable heart monitoring solution suitable for field, home, and clinical settings. It's also the first MDR certified chest strap ECG and heart rate monitor, and one of the first ECG devices overall to achieve MDR certification.

“The MDR certification of the Movesense MD sensor is a major milestone for Movesense and our EU customers, as it enables large-scale clinical use of the device and allows ECG monitoring for larger patient groups and in new usage situations,” said Movesense CEO Jussi Kaasinen.

Related Links:
Movesense Ltd. 

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Coronary Stent System
Ultimaster Sirolimus
New
Vital Signs Monitor
iM3s
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Elana Heart Bypass System is designed to make suturing obsolete (Photo courtesy of AMT Medical)

Pioneering Sutureless Coronary Bypass Technology to Eliminate Open-Chest Procedures

In patients with coronary artery disease, certain blood vessels may be narrowed or blocked, requiring a stent or a bypass (also known as diversion) to restore blood flow to the heart. Bypass surgeries... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.